| Literature DB >> 34788348 |
Aleksandra Kroemeke1, Małgorzata Sobczyk-Kruszelnicka2.
Abstract
OBJECTIVES: According to the social cognitive theory, social support and self-efficacy may interact with each other i.e. compete or account jointly for better adaptation. This study examined the nature of the interaction between coping self-efficacy and received social support in daily lives of patient-caregiver dyads after cancer treatment. We tested whether the effect of daily fluctuations in coping self-efficacy and received support on daily affect was synergistic (positive jointed effect), compensatory (positive competing effect), or interference (negative competing effect).Entities:
Mesh:
Year: 2021 PMID: 34788348 PMCID: PMC8598009 DOI: 10.1371/journal.pone.0260128
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Research model.
Note: paths a5-a8, interaction effects of coping self-efficacy and received support; a1, a3, p1, and p3, main effects of coping self-efficacy; a2, a4, p2, and p4, main effects of received support; a and p, actor and partner effects, respectively; covariances between both, predictors and outcomes are symbolically marked with a two-way arrow.
Characteristic of patient-caregiver dyads (N = 200).
| Demographic and clinical variables | Patients | Caregivers |
|---|---|---|
| Female ( | 86 (43) | 141 (70.5) |
| Age (mean, | 47.85 (13.48) | 47.38 (13.11) |
| Education (mean, | 14.18 (3.32) | 14.07 (3.29) |
| Employment: yes ( | 74 (37.0) | 123 (61.5) |
| Relationship length (mean, | 25.34 (12.26) | 25.34 (12.26) |
| Relationship ties ( | ||
| spouse/partner | 155 (77.5) | 155 (77.5) |
| mother/father | 22 (11.0) | 16 (8.0) |
| daughter/son | 16 (8.0) | 22 (11.0) |
| sister/brother | 6 (3.0) | 6 (3.0) |
| other | 1 (.5) | 1 (.5) |
| Diagnosis ( | ||
| leukemias and other myeloid neoplasms | 35 (17.5) | -- |
| lymphomas | 96 (48.0) | -- |
| multiple myeloma | 62 (31.0) | -- |
| other cancer types | 7 (3.5) | -- |
| Time since diagnosis (mean, | 21.89 (24.07) | -- |
| Transplant type ( | ||
| autologous HCT | 148 (74.0) | -- |
| allogeneic HCT | 52 (26.0) | -- |
| Isolation length (mean, | 18.51 (9.32) | -- |
| autologous HCT recipients | 14.45 (3.52) | -- |
| allogeneic HCT recipients | 30.08 (10.91) | -- |
Leukemias and other myeloid neoplasms include acute lymphoblastic leukemia, acute myeloid leukemia, chronic myelogenous leukemia, myelodysplastic syndrome and myeloproliferative disorders. Lymphomas include Hodgkin and non-Hodgkin type. Other cancer types include solid tumors and other cancers.
Results of concurrent analysis: The fixed effects of daily coping self-efficacy (CSE), received support (RS), and their interaction on same-day affect in 200 patient-caregiver dyads.
| Outcome: | Patient | Caregiver | ||||||
|---|---|---|---|---|---|---|---|---|
| Positive affect | Negative affect | Positive affect | Negative affect | |||||
| Predictor | 95% | 95% | 95% | 95% | ||||
| Intercept | 14.79 (.26) | [14.37; 15.21] | 9.75 (.19) | [9.43; 10.06] | 15.59 (.24) | [15.20; 15.98] | 9.42 (.20) | [9.09; 9.76] |
| Patient CSE | .33 (.03) | [.27; .38] | -.19 (.03) | [-.24; -.14] | .07 (.02) | [.04; .11] | -.04 (.02) | [-.07; -.01] |
| Patient RS | .03 (.03) | [-.02; .07] | .04 (.02) | [-.01; .07] | -.05 (.02) | [-.09; -.01] | .01 (.02) | [-.03; .04] |
| Patient RS × CSE | -.01 (.01) | [-.02; .01] | .01 (.01) | [-.01; .02] | - | - | - | - |
| Patient RS × Caregiver CSE | .00 (.02) | [-.04; .04] | .00 (.01) | [-.02; .02] | - | - | - | - |
| Caregiver CSE | .03 (.02) | [-.01; .07] | -.01 (.02) | [-.04; .02] | .28 (.03) | [.23; .33] | -.19 (.02) | [-.23; -.15] |
| Caregiver RS | .07 (.02) | [.04; .10] | -.07 (.02) | [-.10; -.04] | .11 (.02) | [.08; .15] | -.07 (.02) | [-.10; -.04] |
| Caregiver RS × CSE | - | - | - | - | .00 (.01) | [-.01; .01] | .02 (.01) | [.01; .03] |
| Caregiver RS × Patient CSE | - | - | - | - | .00 (.01) | [-.01; .01] | .01 (.01) | [-.01; .02] |
|
| ||||||||
| Intercept variance | 10.35 (1.19) | [8.39; 12.32] | 5.66 (.47) | [4.89; 6.43] | 8.98 (1.01) | [7.32; 10.64] | 7.58 (.95) | [6.02; 9.14] |
| Residual variance | 5.74 (.35) | [5.16; 6.33] | 3.96 (.31) | [3.46; 4.47] | 7.31 (.49) | [6.50; 8.12] | 4.93 (.35) | [4.35; 5.50] |
Confounders (i.e. age, sex, education, employment, relationship ties/length, and transplant type) were controlled for in the analysis.
Between-person effects are provided in S1 Table.
*p < .05;
**p < .01;
***p < .001.
Fig 2Daily received support by self-efficacy effect on concurrent negative affect in the caregivers.
Panel A = The regions of significance of interaction (solid line = interaction effect, thin lines = 95% confidence interval; when the y-zero-line is included in the confidence bands, the effect of daily deviations in received support on negative affect is not significant). Panel B = Simple slopes for the days with typical and lower than typical (below 2.17 on a scale from -17 to 17), higher than typical, and much higher than typical (above 13.28) daily self-efficacy.
Results of lagged analysis: The fixed effects of daily coping self-efficacy (CSE), received support (RS), and their interaction on next-day affect in 200 patient-caregiver dyads.
| Outcome: | Patient | Caregiver | ||||||
|---|---|---|---|---|---|---|---|---|
| Next-day Positive affect | Next-day Negative affect | Next-day Positive affect | Next-day Negative affect | |||||
| Predictor | 95% | 95% | 95% | 95% | ||||
| Intercept | 14.75(.26) | [14.33; 15.18] | 9.70(.19) | [9.38; 10.01] | 15.60 (.50) | [14.78; 16.41] | 9.47 (.30) | [8.98; 9.95] |
| Patient CSE | .08(.02) | [.04; .11] | -.01(.02) | [-.05; .03] | .01(.05) | [-.06; .08] | .01(.02) | [-.03; .05] |
| Patient RS | .01(.07) | [-.11; .13] | .02(.02) | [-.01; .05] | -.03(.04) | [-.09; .04] | -.01(.02) | [-.04; .03] |
| Patient RS × CSE | .00(.04) | [-.05; .06] | .00(.02) | [-.04; .04] | - | - | - | - |
| Patient RS × Caregiver CSE | .00(.03) | [-.05; .05] | .00(.01) | [-.01; .01] | - | - | - | - |
| Caregiver CSE | .00(.03) | [-.05; .05] | -.02(.02) | [-.05; .01] | .07(.08) | [-.06; .19] | -.01(.03) | [-.06; .04] |
| Caregiver RS | .03(.05) | [-.05; .11] | -.02(.02) | [-.05; .01] | .05(.06) | [-.05; .15] | -.04(.02) | [-.08; .00] |
| Caregiver RS × CSE | - | - | - | - | .02(.02) | [-.02; .03] | .00(.01) | [-.01; .02] |
| Caregiver RS × Patient CSE | - | - | - | - | .01(.05) | [-.07; .09] | .00(.03) | [-.05; .04] |
|
| ||||||||
| Intercept variance | 10.13(1.3) | [7.97; 12.29] | 5.64(.69) | [4.50; 6.78] | 9.11(.93) | [7.58; 10.64] | 7.52(1.24) | [5.48; 9.56] |
| Residual variance | 5.94(.47) | [5.16; 6.72] | 4.03(.34) | [3.48; 4.58] | 8.04(.79) | [6.75; 9.33] | 5.18(.36) | [4.59; 5.77] |
Previous day affect and confounders (i.e. age, sex, education, employment, relationship ties/length, and transplant type) were controlled for in the analysis. Between-person coefficients are presented in S1 Table.
***p < .001.